Page last updated: 2024-12-07

beta-lumicolchicine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Lumicolchicines: Three, alpha, beta, and gamma isomers of ultraviolet degradation products of colchicine that lack many of the physiological actions of the parent; used as experimental control for colchicine actions. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID110937
MeSH IDM0012730

Synonyms (22)

Synonym
nsc-221661
490-24-4
nsc221661
.beta.-lumicolchicine
6901-13-9
6901-14-0
gamma-lumicolchicine
beta-lumicolchicine
n-(1,2,3,9-tetramethoxy-8-oxo-5,6,7,7b,8,10a-hexahydrobenzo[a]cyclopenta[3,4]cyclobuta[1,2-c][7]annulen-7-yl)acetamide
FT-0670875
lumicolchicines
einecs 230-009-7
(7s-(7alpha,7balpha,10aalpha))-n-(5,6,7,7b,8,10a-hexahydro-1,2,3,9-tetramethoxy-8-oxobenzo(a)cyclopenta(3,4)cyclobuta(1,2-c)cyclohepten-7-yl)acetamide
FT-0630355
HMS3372H05
n-(1,2,3,9-tetramethoxy-8-oxo-5,6,7,7b,8,10a-hexahydrobenzo[a]cyclopenta[3,4]cyclobuta[1,2-c]cyclohepten-7-yl)acetamide #
VKPVZFOUXUQJMW-UHFFFAOYSA-N
STL453199
(c)micro-lumicolchicine pound>>lumicolchicine pound>>gamma-lumicolchicine
BCP22727
(c)micro-lumi (-)-colchicine
n-(3,4,5,14-tetramethoxy-13-oxo-10-tetracyclo[9.5.0.02,7.012,16]hexadeca-1(11),2,4,6,14-pentaenyl)acetamide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"5 mg/kg dosage had no significant effects."( The effects of colchicine on prostaglandin I2 and thromboxane A2 biosynthesis in the rat dental pulp.
Hirafuji, M; Ogura, Y, 1988
)
0.27
" Although the log dose-response lines of colchicine and vinblastine were parallel, the effect of vinblastine was more potent."( Comparison of the effect of colchicine and vinblastine on the inhibiton of dentinogenesis in rat incisors.
Mataki, S, 1981
)
0.26
" Dose-response curves (DRCs) to the pigment-concentrating hormone PCH were determined under control and experimental conditions to evaluate the effects elicited by the cytoskeleton-affecting drugs."( Cytoskeleton and PCH-induced pigment aggregation in Macrobrachium potiuna erythrophores.
Castrucci, AM; Josefsson, L; Tuma, MC, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (81)

TimeframeStudies, This Drug (%)All Drugs %
pre-199049 (60.49)18.7374
1990's26 (32.10)18.2507
2000's6 (7.41)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.62 (24.57)
Research Supply Index4.45 (2.92)
Research Growth Index4.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.18%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other84 (98.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]